Terns Pharmaceuticals Inc (NASDAQ: TERN) kicked off on Monday, up 4.29% from the previous trading day, before settling in for the closing price of $4.9. Over the past 52 weeks, TERN has traded in a range of $1.87-$11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 16.38% over the last five years. While this was happening, its average annual earnings per share was recorded -4.94%. With a float of $66.38 million, this company’s outstanding shares have now reached $87.30 million.
The firm has a total of 59 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Terns Pharmaceuticals Inc (TERN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 23.99%, while institutional ownership is 78.92%. The most recent insider transaction that took place on Jul 01 ’25, was worth 3,640. In this transaction Chief Medical Officer of this company sold 853 shares at a rate of $4.27, taking the stock ownership to the 52,464 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Chief Financial Officer bought 10,000 for $3.93, making the entire transaction worth $39,283. This insider now owns 25,000 shares in total.
Terns Pharmaceuticals Inc (TERN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.03% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Take a look at Terns Pharmaceuticals Inc’s (TERN) current performance indicators. Last quarter, stock had a quick ratio of 30.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.21 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Analysing the last 5-days average volume posted by the [Terns Pharmaceuticals Inc, TERN], we can find that recorded value of 1.1 million was lower than the volume posted last year of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 94.37%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 98.24%, which indicates a significant increase from 96.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.62, while its 200-day Moving Average is $4.79. Now, the first resistance to watch is $5.25. This is followed by the second major resistance level at $5.38. The third major resistance level sits at $5.59. If the price goes on to break the first support level at $4.90, it is likely to go to the next support level at $4.68. Should the price break the second support level, the third support level stands at $4.55.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
The company with the Market Capitalisation of 446.30 million has total of 87,337K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -88,850 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -23,910 K.
